why choose us

First received: March 28, 2023

Clinical Trial: A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Asthma

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Positive and Placebo-controlled, Single-dose, Crossover Study of the Effects of CHF5993 pMDI (BDP/FF/GB) at the Proposed Therapeutic and Supratherapeutic Doses, o

Brief Summary: The purpose of this study is to evaluate the potential for cardiac repolarization, according to electrocardiographic monitoring (including QT and QTc intervals), of two dose levels of CHF5993 pMDI (beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/GB)) and of one dose of CHF5259 (GB) in healthy subjects compared to moxifloxacin and placebo.

Read more